BAC-SET MULTIPROBIOTIC: RESULTS OF RUSSIAN AND FOREIGN CLINICAL RESEARCH
https://doi.org/10.21518/2079-701X-2017-19-104-110
Abstract
Gut microflora is a dynamically developing ecosystem. One of the most effective methods to influence to the composition of intestinal microbiota and to restore its metabolic activity is probiotics use. Lately, multi-strain and multi-species probiotics gain greater popularity. The Russian and foreign experience of multi-strain and multi-species sinbiotic Bac-Set Baby and Bac-Set Forte application proves their effectiveness in correction of intestinal microbiota misbalance in functional GIT disorders, constipation and diarrhea in children. The results of studies in children and adult patients allow concluding the fact that Bac-Set Forte multiprobiotic is an auxiliary remedy in the treatment of metabolic syndrome, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
About the Authors
N. G. Sugyan
Russian Medical Academy of the Continuous Professional Education of the Ministry of Health of Russia, Children Municipal Polyclinic No.133 of the Moscow Healthcare Department
Russian Federation
Russian Federation
PhD in medicine,
I. N. Zakharova
Russian Medical Academy of the Continuous Professional Education of the Ministry of Health of Russia, Children Municipal Polyclinic No.133 of the Moscow Healthcare Department
Russian Federation
Russian Federation
MD, Prof.,
References
1. Ho JT, Chan GC, Li JC. Systemic effects of gut microbiota and its relationship with disease and modulation. BMC Immunol, 2015 March, 16(1).
2. Underwood MA, German JB, Lebrilla CB. Bifidjbacterium longum subspecies infants: champion colonizer of the infant gut. Pediatr Research, 2015, 77(0): 229-235.
3. Guarner F, Khan AG, Garisch J, et al. World Gastroenterology Organization. World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics October 2011. J Clin Gastroenterol, 2012, 46: 468–81.
4. United States Department of Health and Human Services Food and Drug Administration, Center for Food Safety and Applied Nutrition. Dietary Supplements Guidance Documents and Regulatory Information.2008.»http://www.fda/gov/ food/guidanceregulation/guidancedocumentsregulatoryinformation/dietarysupplements/default. htm»»pmc_ext» http://www.fda/gov/food/guidanceregulation/guidancedocumentsregulatoryinformation/dietarysupplements/default.htm.
5. Patterns of Early Gut Colonization Shape Future Immune Responses of the Host (Camilla Hart mann Friis Hansen et al; http://journals.plos.org/plosone/ article?id = 10.1371/journal.pone.0034043.
6. Захарова И.Н. Микробиота кишечника ребенка и здоровье: есть ли связь? Медицинский совет, 2015, 6: 47-51.
7. Bekkali N, Bongers M, vanden Berg M, Liem O, Benninga M. The role of probiotics mixture in the treatment of childhood constipation: a pilot study. Nutrition Journal, 2007, 4(6): 17.
8. Sadeghzadeh M, Rabieefar A, Khoshnevisasl P et al. The effect of probiotics on childhood constipation: a randomized controlled double blind clinical trial. Int. J. Pediatr., 2014.
9. Ahmad K, Fatemeh F, Mehri N, Maryam S. Probiotics for the treatment of pediatric helicobacter pylori infection: a randomized double blind clinical trial. Iran J. Pediatr., 2013, 23(1): 79–84.
10. Fallahi G, Motamed F, Yousefi A et al. The effect of probiotics on fecal calprotectin in patients with cystic fibrosis. Turk. J. Pediatr., 2013, 55(5): 475–478.
11. Power ML, Schulkin J. The evolution of obesity. Baltimore, MD: The Johns Hopkins University Press, 2009.
12. Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest, 2011, 121(6): 2126–32.
13. Backhed F et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U.S.A., 2004, 101: 15718–15723.
14. Furet JP et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes, 2010, 59: 3049–3057.
15. Di Baise JK, Zhang H, Crowell MD, et al. Gut microbiota and its relationship with obesity. Mayo Clin. Proc., 2008, 83(4): 460–469.
16. Eslamparast T, Zamani F, Hekmatdoost A et al. Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study. Br. J. Nutr., 2014, 112(3): 438–445.
17. Poustchi H, Zamani F et al. Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study. Am. J. Clin. Nutr., 2014, 99(3): 535–542.
18. Shavakhi A, Minakari M, Firouzian H et al. Effect of a Probiotic and Metformin on Liver Aminotransferases in Non-alcoholic Steatohepatitis: A Double Blind Randomized Clinical Trial. Int. J. Prev. Med., 2013, 4(5): 531–537.
19. Захарова И.Н., Ардатская М.Д., Сугян Н.Г. Влияние мультиштаммового пробиотика на метаболическую активность кишечной микрофлоры у детей грудного возраста с функциональным нарушением желудочно-кишечного тракта: результаты плацебоконтролируемого исследования. Вопросы современной педиатрии, 2016, 15(1): 68-73.
Review
For citations:
Sugyan NG, Zakharova IN. BAC-SET MULTIPROBIOTIC: RESULTS OF RUSSIAN AND FOREIGN CLINICAL RESEARCH. Meditsinskiy sovet = Medical Council. 2017;(19):104-110. (In Russ.) https://doi.org/10.21518/2079-701X-2017-19-104-110
Views:
4673
Email this article 